Literature DB >> 10458343

Time to stone passage for observed ureteral calculi: a guide for patient education.

O F Miller1, C J Kane.   

Abstract

PURPOSE: We analyze the natural history of stone passage in patients with ureterolithiasis, and define factors predictive of spontaneous passage.
MATERIALS AND METHODS: A total of 75 patients with ureteral calculi were prospectively followed for stone passage. Clinical data included patient gender and age, stone size and location, pain medication requirements and interval to stone passage. Of the 75 patients 13 (17%) required intervention and 62 (83%) were followed until spontaneous stone passage. Stones requiring intervention were not included in the time to passage analysis.
RESULTS: Of the 75 patients 41 (55%) had ureteral stones 2 mm. or smaller with an average time to stone passage of 8.2 days and only 2 (4.8%) required intervention, 18 (24%) had stones between 2 and 4 mm. with an average time to stone passage of 12.2 days and 3 (17%) required intervention, and 16 had stones 4 mm. or greater with an average time to stone passage of 22.1 days and 8 required intervention. For 95% of stones to pass it took 31 days for those 2 mm, or less, 40 days for those 2 to 4 mm. and 39 days for those 4 to 6 mm. Multivariate analysis revealed that size, location and side were statistically related to stone passage interval (p = 0.012). Stones that were smaller, more distal and on the right side were more likely to pass spontaneously and required fewer interventions.
CONCLUSIONS: Interval to stone passage is highly variable and dependent on stone size, location and side. Degree of pain, and patient gender and age had no bearing on the time to stone passage. Of ureteral stones 95% 2 to 4 mm. pass spontaneously but passage may take as long as 40 days. Intervention may be required in 50% of ureteral calculi greater than 5 mm.

Entities:  

Mesh:

Year:  1999        PMID: 10458343     DOI: 10.1097/00005392-199909010-00014

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  92 in total

1.  [Infectious diseases and injuries of bladder and urinary tract].

Authors:  J Budjan; P Riffel; M M Ong; C Bolenz; S O Schönberg; S Haneder
Journal:  Radiologe       Date:  2014-11       Impact factor: 0.635

2.  Tamsulosin does not have greater efficacy than conventional treatment for distal ureteral stone expulsion in Mexican patients.

Authors:  Raúl Ochoa-Gómez; Emilio Prieto-Díaz-Chávez; Benjamín Trujillo-Hernández; Clemente Vásquez
Journal:  Urol Res       Date:  2011-04-24

3.  Surgical approach to urolithiasis: the state of art.

Authors:  Riccardo Bartoletti; Tommaso Cai
Journal:  Clin Cases Miner Bone Metab       Date:  2008-05

4.  The management of ureteric stones.

Authors:  S Phipps; D A Tolley; J G Young; F X Keeley
Journal:  Ann R Coll Surg Engl       Date:  2010-07       Impact factor: 1.891

5.  Efficacy of silodosin in the treatment of distal ureteral stones 4 to 10 mm in diameter.

Authors:  Mustafa Yuksel; Serdar Yilmaz; Husnu Tokgoz; Soner Yalcinkaya; Serkan Baş; Tümay Ipekci; Ali Yildiz; Nihat Ates; Murat Savas
Journal:  Int J Clin Exp Med       Date:  2015-10-15

6.  CUA Guideline: Management of ureteral calculi.

Authors:  Michael Ordon; Sero Andonian; Brian Blew; Trevor Schuler; Ben Chew; Kenneth T Pace
Journal:  Can Urol Assoc J       Date:  2015-12-14       Impact factor: 1.862

7.  Adjunctive therapy to promote stone passage.

Authors:  Geoffrey R Nuss; Judson D Rackley; Dean G Assimos
Journal:  Rev Urol       Date:  2005

8.  Can the Hounsfield unit predict the success of medically expulsive therapy?

Authors:  Sakip Erturhan; Omer Bayrak; Ahmet Mete; Ilker Seckiner; Gokhan Urgun; Kemal Sarica
Journal:  Can Urol Assoc J       Date:  2013 Nov-Dec       Impact factor: 1.862

9.  Pediatric primary urolithiasis: Symptoms, medical management and prevention strategies.

Authors:  Maria Goretti Moreira Guimarães Penido; Marcelo de Sousa Tavares
Journal:  World J Nephrol       Date:  2015-09-06

10.  Ureteral stones due to systemic mastocytosis: diagnostic and therapeutic characteristics.

Authors:  Gerhard J Molderings; Gerold Solleder; Ulrich W Kolck; Jürgen Homann; Detlev Schröder; Ivar von Kügelgen; Roland Vorreuther
Journal:  Urol Res       Date:  2009-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.